Trial Outcomes & Findings for Model 20105 Lead Study (NCT NCT02301429)
NCT ID: NCT02301429
Last Updated: 2016-10-26
Results Overview
All Implant procedure and lead related adverse events will be collected during the first month post implant and analyzed.
Recruitment status
TERMINATED
Study phase
NA
Target enrollment
16 participants
Primary outcome timeframe
1 month
Results posted on
2016-10-26
Participant Flow
Participant milestones
| Measure |
Model 20105
Receiving the model 20105 Lead
Model 20105: implant and follow-up of study device
|
|---|---|
|
Overall Study
STARTED
|
16
|
|
Overall Study
COMPLETED
|
13
|
|
Overall Study
NOT COMPLETED
|
3
|
Reasons for withdrawal
| Measure |
Model 20105
Receiving the model 20105 Lead
Model 20105: implant and follow-up of study device
|
|---|---|
|
Overall Study
not acceptable vascular anatomy
|
3
|
Baseline Characteristics
Model 20105 Lead Study
Baseline characteristics by cohort
| Measure |
Model 20105
n=16 Participants
Receiving the model 20105 Lead
Model 20105: implant and follow-up of study device
|
|---|---|
|
Age, Continuous
|
73.2 years
STANDARD_DEVIATION 11.2 • n=5 Participants
|
|
Sex: Female, Male
Female
|
8 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
8 Participants
n=5 Participants
|
|
QRS duration
|
108.7 msec
STANDARD_DEVIATION 17.6 • n=5 Participants
|
PRIMARY outcome
Timeframe: 1 monthPopulation: all subject who underwent a Model 20105 Lead implant attempt are considered in this analysis
All Implant procedure and lead related adverse events will be collected during the first month post implant and analyzed.
Outcome measures
| Measure |
Model 20105
n=13 Participants
Receiving the model 20105 Lead
Model 20105: implant and follow-up of study device
|
|---|---|
|
All Implant Procedure and Lead Related Adverse Events Will be Collected During the First Month Post Implant and Analyzed.
|
3 Adverse Events
|
Adverse Events
Model 20105
Serious events: 3 serious events
Other events: 3 other events
Deaths: 0 deaths
Serious adverse events
| Measure |
Model 20105
n=13 participants at risk
Receiving the model 20105 Lead
Model 20105: implant and follow-up of study device
|
|---|---|
|
Injury, poisoning and procedural complications
Coronary Sinus Dissection
|
7.7%
1/13 • Number of events 1
|
|
Injury, poisoning and procedural complications
Iatrogenic pneumothorax
|
7.7%
1/13 • Number of events 1
|
|
Surgical and medical procedures
Coronary Artery Stent Insertion
|
7.7%
1/13 • Number of events 1
|
Other adverse events
| Measure |
Model 20105
n=13 participants at risk
Receiving the model 20105 Lead
Model 20105: implant and follow-up of study device
|
|---|---|
|
Injury, poisoning and procedural complications
Coronary Sinus Dissection
|
7.7%
1/13 • Number of events 1
|
|
Cardiac disorders
Atrioventricular nodal reentrant tachycardia
|
7.7%
1/13 • Number of events 1
|
|
Cardiac disorders
Angina Pectoris
|
7.7%
1/13 • Number of events 1
|
Additional Information
Clinical Study manager
Medtronic Regional Clinical Center
Phone: 0039(0)22 241371
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place
Restriction type: GT60